Urgent

Sneddon syndrome

Vascular skin · Dermatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A non-inflammatory arteriopathy combining widespread livedo racemosa with recurrent ischaemic strokes, often associated with antiphospholipid antibodies.

Red flags

  • Acute stroke / TIA
  • Cognitive decline
  • Positive antiphospholipid antibodies
  • Recurrent thrombotic events

Assessment

Differential diagnosis

  • Antiphospholipid syndrome
  • Vasculitis
  • Cholesterol embolisation
  • Thrombotic microangiopathy
  • CADASIL

Investigations

  • MRI brain (ischaemic lesions)
  • Antiphospholipid antibody screen
  • Skin biopsy of livedo
  • Thrombophilia screen
  • Echocardiography / vascular assessment

Management

  • Assess for acute stroke and manage per stroke pathway
  • Recognise the livedo-plus-stroke pattern
  • Screen for antiphospholipid antibodies
  • Neurology and dermatology / rheumatology referral
  • Antithrombotic therapy (specialist decision)
  • Manage vascular risk factors

Drugs & doses

Antiplatelet or anticoagulant therapy (specialist)
Vascular risk factor modification
Manage acute stroke per protocol

Disposition

Admit for stroke workup; neurology + dermatology/rheumatology.

Complications & pitfalls

  • Recurrent stroke
  • Vascular dementia
  • Systemic thrombosis

Exam pearls

  • Consider it in a young patient with stroke and widespread livedo racemosa.
  • Antiphospholipid antibodies are frequently positive.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.